{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:31:06Z","timestamp":1769275866514,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clbc.2024.06.014","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T18:26:17Z","timestamp":1719339977000},"page":"e40-e47.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integration of Radiomics and Immune-Related Genes Signatures for Predicting Axillary Lymph Node Metastasis in Breast Cancer"],"prefix":"10.1016","volume":"25","author":[{"given":"Xue","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2024.06.014_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Canc J Clin"},{"key":"10.1016\/j.clbc.2024.06.014_bib0002","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/radiol.2020192534","article-title":"Axillary nodal evaluation in breast cancer: state of the art","volume":"295","author":"Chang","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2024.06.014_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clbc.2024.06.014_bib0004","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/bib\/bbaa026","article-title":"Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer","volume":"22","author":"Y","year":"2021","journal-title":"Briefings Bioinf"},{"key":"10.1016\/j.clbc.2024.06.014_bib0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00330-019-06371-w","article-title":"A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma","volume":"30","author":"P","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clbc.2024.06.014_bib0006","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s00330-017-5005-7","article-title":"Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI","volume":"28","author":"H","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clbc.2024.06.014_bib0007","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jmri.26224","article-title":"Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI","volume":"49","author":"L","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.clbc.2024.06.014_bib0008","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1148\/radiol.2018172171","article-title":"Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment","volume":"287","author":"Pinker","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2024.06.014_bib0009","article-title":"A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma","volume":"13","author":"H","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.clbc.2024.06.014_bib0010","article-title":"Development and validation of a radiogenomics model to predict axillary lymph node metastasis in breast cancer integrating MRI with transcriptome data: a multicohort study","volume":"12","author":"F","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.clbc.2024.06.014_bib0011","doi-asserted-by":"crossref","first-page":"17787","DOI":"10.1038\/srep17787","article-title":"Deciphering genomic underpinnings of quantitative MRI-based radiomic phenotypes of invasive breast carcinoma","volume":"5","author":"Zhu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.clbc.2024.06.014_bib0012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40644-019-0233-5","article-title":"Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling","volume":"19","author":"Yeh","year":"2019","journal-title":"Cancer Imag"},{"key":"10.1016\/j.clbc.2024.06.014_bib0013","doi-asserted-by":"crossref","first-page":"E104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2024.06.014_bib0014","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2024.06.014_bib0015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1200\/JCO.2014.56.6661","article-title":"Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer","volume":"33","author":"Liang","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.06.014_bib0016","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1158\/1078-0432.CCR-17-1510","article-title":"A radiomics nomogram for the preoperative prediction of lymph node metastasis in bladder cancer","volume":"23","author":"Wu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2024.06.014_bib0017","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.clbc.2023.04.002","article-title":"Development and validation of a nomogram for predicting axillary lymph node metastasis in breast cancer","volume":"23","author":"Li","year":"2023","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2024.06.014_bib0018","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.clbc.2024.06.014_bib0019","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.clbc.2024.06.014_bib0020","article-title":"CXCL5: a coachman to drive cancer progression","volume":"12","author":"J","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.clbc.2024.06.014_bib0021","first-page":"e21181","article-title":"Crosstalk between head and neck cancer cells and lymphatic endothelial cells promotes tumor metastasis via CXCL5-CXCR2 signaling","volume":"35","author":"S","year":"2021","journal-title":"FASEB J"},{"key":"10.1016\/j.clbc.2024.06.014_bib0022","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1038\/s41467-019-12108-6","article-title":"The CXCL5\/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis","volume":"10","author":"R","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.clbc.2024.06.014_bib0023","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1038\/onc.2014.10","article-title":"MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis","volume":"33","author":"Chan","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.clbc.2024.06.014_bib0024","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/bcr2224","article-title":"Transforming growth factor-beta in breast cancer: too much, too late","volume":"11","author":"H","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2024.06.014_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10549-011-1499-x","article-title":"Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets","volume":"128","author":"M","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2024.06.014_bib0026","doi-asserted-by":"crossref","first-page":"10097","DOI":"10.4238\/2014.December.4.4","article-title":"Analysis of signaling pathways in recurrent breast cancer","volume":"13","author":"Z","year":"2014","journal-title":"Genet Molecul Res"},{"key":"10.1016\/j.clbc.2024.06.014_bib0027","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.humpath.2009.03.006","article-title":"Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma","volume":"40","author":"J","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clbc.2024.06.014_bib0028","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/ncomms6135","article-title":"Variation in genomic landscape of clear cell renal cell carcinoma across Europe","volume":"5","author":"G","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.clbc.2024.06.014_bib0029","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/1477-3163.90677","article-title":"The two faces of Janus kinases and their respective STATs in mammary gland development and cancer","volume":"10","author":"Kay-Uwe","year":"2011","journal-title":"J Carcinogen"},{"key":"10.1016\/j.clbc.2024.06.014_bib0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"M","year":"2014","journal-title":"Nat Rev Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924001794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924001794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:00:29Z","timestamp":1736301629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820924001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1526820924001794"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.06.014","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integration of Radiomics and Immune-Related Genes Signatures for Predicting Axillary Lymph Node Metastasis in Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}